Application of Nano Drugs in Treatment of Leishmaniasis
Journal: Global Journal of Infectious Diseases and Clinical Research (Vol.2, No. 1)Publication Date: 2016-10-12
Authors : Seyed Hossein Shahcheraghi Jamshid Ayatollahi Marzieh Lotfi Ali Fattahi Bafghi; Seyed Hossein Khaleghinejad;
Page : 018-020
Keywords : Cutaneous leishmaniasis; Visceral leishmaniasis; Nano drugs;
Abstract
Objective: Leishmaniasis is endemic in 88 countries with incidence rate of 1.5-2 million; the most common form of leishmaniasis is cutaneous leishmaniasis (CL) with 1.5 million new cases per year. Correct diagnosis and characterization of the particular parasite is important for evaluating prognosis and prescribing appropriate treatment. The current management of leishmaniasis is drug treatment of patients, to alleviate disease and vector control to reduce its transmission. Also, current treatments for visceral leishmaniasis are unsatisfactory because of their toxicity, resistance and high cost. The purpose of the present study was to review the application of nano drugs in treatment of leishmaniasis.
Other Latest Articles
- The Immunologic Relationship between Root Resorptions and Osteoclastic Activity - Literature Review
- PCR-Based Method for Rapid and Minimized Electrochemical Detection of mecA Gene of Methicillin-Resistant Staphylococcus aureus and Methicillin-Resistant Staphylococcus epidermis
- A Literature Review of Inflammation and Its Relationship with the Oral Cavity
- Antibacterial Effects of Herbal Compounds against Acinetobacter baumannii Isolated from Hospital of Tehran, Iran
- Pivmecillinam Treatment of Community-Acquired Uncomplicated Pyelonephritis Based on Sparse Data
Last modified: 2018-09-12 13:51:49